213 related articles for article (PubMed ID: 22363752)
1. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.
Calderon LE; Liu S; Su W; Xie Z; Guo Z; Eberhard W; Gong MC
PLoS One; 2012; 7(2):e31850. PubMed ID: 22363752
[TBL] [Abstract][Full Text] [Related]
2. Group VIA phospholipase A2 (iPLA2beta) participates in angiotensin II-induced transcriptional up-regulation of regulator of g-protein signaling-2 in vascular smooth muscle cells.
Xie Z; Gong MC; Su W; Turk J; Guo Z
J Biol Chem; 2007 Aug; 282(35):25278-89. PubMed ID: 17613534
[TBL] [Abstract][Full Text] [Related]
3. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
4. Involvement of vascular peroxidase 1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Shi R; Hu C; Yuan Q; Yang T; Peng J; Li Y; Bai Y; Cao Z; Cheng G; Zhang G
Cardiovasc Res; 2011 Jul; 91(1):27-36. PubMed ID: 21292788
[TBL] [Abstract][Full Text] [Related]
5. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation.
Cheng JF; Ni GH; Chen MF; Li YJ; Wang YJ; Wang CL; Yuan Q; Shi RZ; Hu CP; Yang TL
Vascul Pharmacol; 2011; 55(1-3):34-41. PubMed ID: 21586339
[TBL] [Abstract][Full Text] [Related]
6. Smooth muscle-specific expression of calcium-independent phospholipase A2β (iPLA2β) participates in the initiation and early progression of vascular inflammation and neointima formation.
Liu S; Xie Z; Zhao Q; Pang H; Turk J; Calderon L; Su W; Zhao G; Xu H; Gong MC; Guo Z
J Biol Chem; 2012 Jul; 287(29):24739-53. PubMed ID: 22637477
[TBL] [Abstract][Full Text] [Related]
7. Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates proliferation of vascular smooth muscle cells and vascular remodeling in spontaneously hypertensive rats.
Zhang HG; Cheng YQ; Liu Y; Zhou JZ; Jia Y; Wang XQ; Li XH
Biol Pharm Bull; 2011; 34(10):1527-32. PubMed ID: 21963491
[TBL] [Abstract][Full Text] [Related]
8. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.
Xie Z; Liu D; Liu S; Calderon L; Zhao G; Turk J; Guo Z
J Biol Chem; 2011 Dec; 286(52):44646-58. PubMed ID: 22057271
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of Gqα and PLC-β1 proteins contributes to vascular smooth muscle cell hypertrophy in SHR: role of endogenous angiotensin II and endothelin-1.
Atef ME; Anand-Srivastava MB
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C97-106. PubMed ID: 24760983
[TBL] [Abstract][Full Text] [Related]
10. HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model.
Bai L; Kee HJ; Choi SY; Seok YM; Kim GR; Kee SJ; Kook H; Jeong MH
Biomed Pharmacother; 2021 Feb; 134():111162. PubMed ID: 33360932
[TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of calcium-independent phospholipase A(2)beta causes hypercontractility and markedly attenuates endothelium-dependent relaxation to acetylcholine.
Dietrich HH; Abendschein DR; Moon SH; Nayeb-Hashemi N; Mancuso DJ; Jenkins CM; Kaltenbronn KM; Blumer KJ; Turk J; Gross RW
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2208-20. PubMed ID: 20382858
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
Sparks MA; Parsons KK; Stegbauer J; Gurley SB; Vivekanandan-Giri A; Fortner CN; Snouwaert J; Raasch EW; Griffiths RC; Haystead TA; Le TH; Pennathur S; Koller B; Coffman TM
Hypertension; 2011 Mar; 57(3):577-85. PubMed ID: 21242463
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
Touyz RM; He G; El Mabrouk M; Diep Q; Mardigyan V; Schiffrin EL
J Hypertens; 2001 Mar; 19(3 Pt 2):553-9. PubMed ID: 11327629
[TBL] [Abstract][Full Text] [Related]
15. Role of IκB kinase-β in the growth-promoting effects of angiotensin II in vitro and in vivo.
Doyon P; van Zuylen WJ; Servant MJ
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2850-7. PubMed ID: 24135021
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II shifts insulin signaling into vascular remodeling from glucose metabolism in vascular smooth muscle cells.
Hitomi H; Kaifu K; Fujita Y; Sofue T; Nakano D; Moriwaki K; Hara T; Kiyomoto H; Kohno M; Kobori H; Nishiyama A
Am J Hypertens; 2011 Oct; 24(10):1149-55. PubMed ID: 21716329
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice.
Gao P; Xu TT; Lu J; Li L; Xu J; Hao DL; Chen HZ; Liu DP
J Mol Med (Berl); 2014 Apr; 92(4):347-57. PubMed ID: 24352856
[TBL] [Abstract][Full Text] [Related]
18. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
[TBL] [Abstract][Full Text] [Related]
19. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
20. Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats.
Dilley RJ; Nataatmadja MI
Cardiovasc Res; 1998 Apr; 38(1):247-55. PubMed ID: 9683928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
